Alteration of myocardial GRK2 produces a global metabolic phenotype
Authors:
- Benjamin P. WoodallBWBenjamin P. Woodall
- Kenneth S. GreshamKGKenneth S. Gresham
- Meryl A. WoodallMWMeryl A. Woodall
- Mesele-Christina ValentiMVMesele-Christina Valenti
- Alessandro CannavoACAlessandro Cannavo
- Jessica PflegerJPJessica Pfleger
- J. Kurt ChuprunJCJ. Kurt Chuprun
- Konstantinos DrosatosKDKonstantinos Drosatos
- Walter J. KochWKWalter J. Koch
- 16 May 2019
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 4 (10)
Abstract
A vast body of literature has established G protein–coupled receptor kinase 2 (GRK2; family: β-adrenergic receptor kinases [βARKs]) as a key player in the development and progression of heart failure. Inhibition of GRK2 improves cardiac function after injury in numerous animal models. In recent years, discovery of several noncanonical GRK2 targets has expanded our view of this kinase. This article describes the exciting finding that cardiac GRK2 activity can regulate whole-body metabolism. Transgenic mice with cardiac-specific expression of a peptide inhibitor of GRK2 (TgβARKct) display an enhanced obesogenic phenotype when fed a high-fat diet (HFD). In contrast, mice with cardiac-specific overexpression of GRK2 (TgGRK2) show resistance to HFD-induced obesity. White adipose tissue (WAT) mass was significantly enhanced in HFD-fed TgβARKct mice. Furthermore, regulators of adipose differentiation were differentially regulated in WAT from mice with gain or loss of GRK2 function. Using complex metabolomics, we found that cardiac GRK2 signaling altered myocardial branched-chain amino acid (BCAA) and endocannabinoid metabolism. In addition, it modulated circulating BCAA and endocannabinoid metabolite profiles on mice fed an HFD. We also found that one of the BCAA metabolites identified here enhances adipocyte differentiation in vitro. These results suggest that metabolic changes in the heart due to GRK2 signaling on mice fed an HFD control whole-body metabolism.Keywords
Funding Information
- American Heart Association (18MERIT33900036)
- NIH/NHLBI/Duke University (P01HL075443)
- NIH/NHLBI (T32HL09184)
- NIH/NHLBI (R37HL061690)
- American Heart Association (11PRE6690003)
- NIH/NHLBI (K99/R00 HL112853)
- W.W.Smith Charitable Trust (H1705)
This publication has 53 references indexed in Scilit:
- A Cardiac MicroRNA Governs Systemic Energy Homeostasis by Regulation of MED13Cell, 2012
- Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytesJournal of Clinical Investigation, 2012
- A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesisNature, 2012
- Adipose tissue remodeling and obesityJournal of Clinical Investigation, 2011
- G Protein–Coupled Receptor Kinase 2 Activity Impairs Cardiac Glucose Uptake and Promotes Insulin Resistance After Myocardial IschemiaCirculation, 2011
- Metabolite profiles and the risk of developing diabetesNature Medicine, 2011
- Body Mass Index and Vigorous Physical Activity and the Risk of Heart Failure Among MenCirculation, 2009
- Myocardial Adeno-Associated Virus Serotype 6–βARKct Gene Therapy Improves Cardiac Function and Normalizes the Neurohormonal Axis in Chronic Heart FailureCirculation, 2009
- Modulation of the Endocannabinoid System in Cardiovascular DiseaseHypertension, 2008
- Multiple pathways involved in the biosynthesis of anandamideNeuropharmacology, 2008